Global - Pharmaceutical Executive

ADVERTISEMENT

Global

Surviving the Emerging Market Price Wars: Three Myths & Three Lessons

June 29, 2014

How big Pharma stalwarts can avoid a corrosive battle of attrition with local competitors and instead obtain the long-term goal of a stable pricing environment.

"Market-Based" Price Controls In India?

April 1, 2014

Three strategic implications for pharma pricing strategies in India.

Growing Pains: The European Medicines Agency at 20

February 3, 2014

Reflector looks at the growing pains of the European Medicine Agency (EMA) as it faces the key policy challenges of 2014.

Takeda's Oncology Taskmaster

February 1, 2014

Millennium Takeda's new president, Anna Protopapas, explains the life choices that brought her from Cyprus to Cambridge—and a lead position in the hotly contested search to make cancer a treatable disease.

Will Europe's Regulatory Watchdog Come Of Age In 2014?

February 1, 2014

Reflector looks at the growing pains of the European Medicine Agency (EMA) as it faces key policy challenges of 2014.

Russia's Bet on Biopharma

January 21, 2014

Can innovation trump ideology? Russia faces a stark choice in betting on the visible hand of government in promoting a "world class" biopharmaceutical sector, writes William Looney.

Pay for Delay?

October 1, 2013

Europe follows the United States with a harsh new spotlight on agreements that slow generic entry for medicines losing exclusivity.

Divining the Future of Devices

October 1, 2013

European efforts to crack down on safety and pricing issues in the marketing of medical devices may portend long-term problems for Big Pharma.

T-TIPing the Balance in Industry's Favor

September 1, 2013

By the start of 2014, industry expects to have a clearer idea of how far the US-EU free trade pact is going.

ADVERTISEMENT

Click here